Data from Oncomine database [30] also indicated that CHD5 mRNA expression was frequently decreased in kidney [31–33], bladder [34] and prostate cancers [35] compare with their adjacent control tissues (Supplementary Table 1). Here, CHD5 is linked to prostate carcinoma.